Core Insights - Linhua Medical's total revenue for the first half of 2025 reached 456 million yuan, representing a year-on-year growth of 0.74% [1] - The company's net profit was 87.58 million yuan, showing a decline of 10.72% compared to the same period last year [1] - Earnings per share stood at 0.24 yuan, with a return on equity of 7.57% and operating cash flow per share of 0.2051 yuan [1] - The gross profit margin for sales was reported at 68.20% [1] Company Overview - Linhua Medical was established in 1996 and is located at No. 3 Weixin Road, Suzhou Industrial Park [1] - The company specializes in the research, production, and sales of clinical vascular drug delivery tools [1] - It has a registered capital of 360 million yuan, with Wu Wenyuan as the legal representative [1] Investment and Intellectual Property - Linhua Medical has invested in 19 companies and participated in 391 bidding projects [1] - The company holds 44 trademark registrations and 252 patent filings [1] - Additionally, it possesses 127 administrative licenses [1]